4th RNA Vaccines and Therapeutics Conference: 15 - 16 September 2026, London

Returning for a fourth year in 2026, the two-day RNA Vaccines and Therapeutics Conference will focus on the most recent developments in the rapidly evolving science of encoded RNA medicines.

Hosted by CPI, Imperial College London, and The BioIndustry Association (BIA), this two-day event will bring together a diverse range of experts from academia, biotech, pharma, and governmental and non-governmental agencies with a mix of invited and abstract-selected speakers together with poster sessions.

To find more information and continue to the conference page please click on the register button.

Agenda day 1 - Tuesday 15 September

9:15 — 9:30: Welcome address
Robin Shattock, Professor at Imperial College London

9:30 ‑10:15: Keynote
The past, present and future of the nucleoside-modified mRNA technology — Norbert Pardi, Associate Professor at University of Pennsylvania Perelman School of Medicine.

10:15 — 11:05: Session 1 — RNA design and optimisation
- A fully synthetic process to enable GMP-compatible scale-out manufacture of personalised mRNA-based therapeutics — Aiswarya Thulasi, 4BaseBio.
- Advancing the field of neoantigen design — Thomas Guyon, Quantoom Biosciences.
- Enzymatic dsRNA removal improves mRNA and saRNA performance and reduces innate immune activation — Mark Livingstone, CELLSCRIPT.

11:05 — 11:35 — Networking break.

11:35 — 12:40: Session 2 — Formulation design and development
- Engineering polymeric nanocarriers for oral and systemic mRNA delivery — Piotr Kowalski, University College Cork.
- Systematic LNP Screening Identifies Efficient Ex Vivo mRNA Delivery to Primary Murine CD8⁺ T Cells — Paraskevi Tsodoulou, University of Ghent, Imperial College London.
- Refinement of residual solvent in polymeric nanoformulation for mucosal vaccination in a murine influenza model — Asha Patel, Imperial College London.
- Accelerated ageing alters lipid nanoparticle properties and enhances mRNA delivery to immune cells — Joas Sterk, University of Sheffield.

12:40 — 13:55: Lunch and networking.

13:55 — 14:55: Panel discussion.

14:55 — 15:30: Poster flash session.

15:30 — 16:00: Networking break.

16:00 — 17:15: Session 3 — RNA process modelling and manufacture (AI and digitisation).
- Monitoring Mg2+ in IVT reaction enhances yield and quality of mRNA — Rok Sekirnik, Sartorius BIA Separations.
- RiboFlux TM: a flow-based, fully automated and GMP compliant manufacturing system for ultra-scalable and on-demand E‑2-E manufacturing of formulated mRNA — Aliene Alting, RiboPro B.V..
- Holistic Model-based Assessment of RNA Platform Manufacturing Economics — Simon Daniel, Imperial College London.
- Mechanistically Informed Reduction of In Vitro Transcription Models for Practical Process Development — Pramuditha Mendis, University of Sheffield.

17:15 — 17:45: Keynote
Saranya Sridhar, VP, Head of Global Clinical Development, Vaccines Sanofi.

17:45 — 19:00 — Drinks reception.

Agenda day 2 - ~Wednesday 16 September

9:15 — 9:20: Welcome

9:20 — 10:05: Keynote: Immunological mechanisms of mRNA vaccines, Karin Lore, Professor at Center for Molecular Medicine, Karolinska Institutet.

10:05 — 11:05: Session 4 — RNA and formulation analytics
- Biochemical and biophysical analysis of mRNA multimers: New insights into mRNA structure and function, Mark Dickman, University of Sheffield.
- Solid-State Nanopore Sensing Characterises Topology Of Therapeutic Circular RNA — Raluca-Elena Alexii, University of Cambridge.
- Comprehensive Characterisation of circRNA Therapeutics — Adam Miah, University of Sheffield.

10:50 — 11:20 — Networking break.

11:20 — 11:45 — Quick fire pitches.

11:45 — 13:00: Session 5 — Therapeutics – preclinical and clinical evaluation
- Design, manufacture and clinical translation of a multivalent haemorrhagic saRNA vaccine — Robin Shattock and Philip Probert, Imperial College London and CPI.
- Pre-clinical development of next generation RNA rotavirus vaccines — Krunal Polra, Imperial College London.
- Improving LNP formulations using 3D tissue cultre models of paediatric brain tumours — Oliver Meeds, University of Nottingham.
- Local pulmonary delivery of extended-stability IL-10 mRNA polyplexes attenuates lipopolysaccharide-induced lung inflammation — Alexander Jenkins, Imperial College London.

13:00 — 14:00 — Lunch and networking.

14:00 — 14:55: Session 6 — Vaccines: preclinical and clinical evaluation
- Cesar Lopez-Camacho, University of Oxford.
- Boosting LNP performance with promising next generation lipids — Sophie Hammer, Evonik Operations.
- Enzymatically Synthesized Linear DNA Templates enabling IVT mRNA Yields, Product Quality, and PolyA Tail Homogeneity — Jaya Selvaraj, 4basebio.

14:55 — 15:25 — Networking break.

15:25 ‑16:10: Keynote: William Schief, Vice-President Protein Design, Moderna.

16:10 — 16:30 — Poster prizes.

16:30 — 16:40 — Conference wrap-up.

16:40 Conference close.

Sponsorship Opportunities

Download the official Sponsorship Brochure for the RNA Vaccines & Therapeutics Conference – London 2026 to explore high-impact branding and engagement opportunities.

With exclusive headline, poster, drinks, lunch and associate packages available, this is your opportunity to position your organisation at the heart of next-generation RNA innovation.

Abstract submissions

We are pleased to invite abstract submissions for the conference.

We are particularly keen to receive abstracts that showcase new scientific data, clear results, and meaningful developments. Submissions that are more descriptive in nature or do not include supporting evidence are less likely to be selected.

Please note that acceptance of an abstract does not include a conference ticket, so presenters will need to register separately to attend.

By submitting your abstract, you agree to it being published online and included in post-event materials.

The deadline for abstract submisson is 7 July 2026 at 5pm. Applicants will be advised on the outcome of their abstract application by email by 31 July 2026.

Contact

For more information, please contact events@​uk-​cpi.​com.